ArticleArthritis & rheumatology (Hoboken, N.J.)2017

Limited Value of the Multi-Biomarker Disease Activity Assay Compared to the Routine Assessment of Patient Index Data 3 (RAPID3) Score in the Prognosis of Important Clinical Outcomes in Rheumatoid Arthritis: Comment on the Article by Fleischmann et al and Accompanying Editorial by Davis.

Theodore Pincus et al.PubMed ↗Publisher ↗

No numbers read from the abstract.